APYX vs CE · rev $48.1M vs rev $10.28B
Apyx Medical Inc (APYX) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
APYX currently screens at market cap $179.6M. CE currently screens at market cap $5.92B.
Not investment advice. Open the APYX and CE stock pages for the full models.
Not investment advice.